Enoxaparin Sodium Injection
Product Images NDC 0781-3256

30 FDA label images from Sandoz Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 30 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 0781-3256). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Enoxaparin Figure A (Enoxaparin 01)

Enoxaparin Figure A (Enoxaparin 01)
Illustration showing two hands holding a prefilled syringe for injection. One hand is removing or applying the needle cap, indicated by a double-headed arrow between the syringe and the cap. The syringe resembles an injection device for Enoxaparin Sodium subcutaneous use.*
FDA Label Image

Enoxaparin-figure-b (Enoxaparin 02)

Enoxaparin-figure-b (Enoxaparin 02)
An instructional illustration showing a hand administering an injection with a prefilled syringe into the palm of the other hand, demonstrating the injection technique typically used for subcutaneous administration.*
FDA Label Image

Enoxaparin Figure C (Enoxaparin 03)

Enoxaparin Figure C (Enoxaparin 03)
An illustration showing a hand holding a syringe with a needle being inserted at a subcutaneous injection site, depicting the administration technique for an injection.*
FDA Label Image

Enoxaparin Figure D (Enoxaparin 04)

Enoxaparin Figure D (Enoxaparin 04)
An instructional black-and-white illustration showing a hand holding a prefilled syringe, with an arrow indicating the motion or direction to pull back on the syringe plunger. The image appears to demonstrate proper use or preparation of the injection device.*
FDA Label Image

Enoxaparin Figure E (Enoxaparin 05)

Enoxaparin Figure E (Enoxaparin 05)
An instructional illustration showing a gloved hand disposing of a syringe into a container labeled with a biohazard symbol. The image visually guides proper disposal of injection needles or syringes into a designated sharps or biohazard waste container.*
FDA Label Image

Enoxaparin Sodium Chemical Structure (Enoxaparin 06)

Enoxaparin Sodium Chemical Structure (Enoxaparin 06)
Chemical structure diagram of Enoxaparin Sodium showing its polysaccharide chain, including annotations for R, R1, and R2 groups and the proportion of polysaccharide chains containing 1,6 anhydro derivatives at the reducing end. The image depicts the molecular components and chain length variations of this anticoagulant agent.*
FDA Label Image

Figure-1 (Enoxaparin 07)

Figure-1 (Enoxaparin 07)
A forest plot displaying relative risk comparisons between Enoxaparin Sodium and unfractionated heparin (UFH) across various patient subgroups in a clinical study. The chart lists patient subgroups, number of patients per group, relative risk values, percentages for UFH and Enoxaparin treatments, and risk reduction percentages, illustrating Enoxaparin's favorable outcomes in several categories.*
FDA Label Image

Figure-2 (Enoxaparin 08)

Figure-2 (Enoxaparin 08)
A hazard distribution function chart comparing time to death or myocardial re-infarction over 30 days between Enoxaparin and UFH treatments. The graph includes two labeled curves with Enoxaparin showing a lower hazard than UFH. An inset chart extends this comparison to 1 year. The bottom of the chart displays the number at risk for each group across various time points.*
FDA Label Image

Enoxaparin Parts Of Injection (Enoxaparin 09)

Enoxaparin Parts Of Injection (Enoxaparin 09)
An instructional illustration depicting a syringe before and after use, showing labeled parts including the plunger rod, needle, needle cap before use, and the protective sleeve after use. The syringe design appears relevant for subcutaneous injection administration, such as for Enoxaparin Sodium injection.*
FDA Label Image

Enoxaparin Ifu Figure A (Enoxaparin 10)

Enoxaparin Ifu Figure A (Enoxaparin 10)
An instructional illustration labeled Figure A showing items for subcutaneous injection of Enoxaparin Sodium. It includes a sharps disposal container, one cotton ball or gauze, one alcohol wipe, one small adhesive bandage, and the Enoxaparin syringe.*
FDA Label Image

Enoxaparin Ifu Figure B (Enoxaparin 11)

Enoxaparin Ifu Figure B (Enoxaparin 11)
An instructional illustration labeled Figure B showing two hands preparing a prefilled syringe. One hand holds the syringe, while the other removes a protective cover or backing, demonstrating part of the injection preparation process for Enoxaparin Sodium subcutaneous injection.*
FDA Label Image

Enoxaparin Ifu Figure C (Enoxaparin 12)

Enoxaparin Ifu Figure C (Enoxaparin 12)
Illustration labeled 'Figure C' showing a side view of a prefilled syringe for Enoxaparin Sodium injection. The image highlights the location of the expiration date on the syringe barrel near the plunger section.*
FDA Label Image

Enoxaparin Ifu Figure D (Enoxaparin 13)

Enoxaparin Ifu Figure D (Enoxaparin 13)
Illustration labeled Figure D showing a syringe with a clear liquid inside the barrel, highlighting the presence of clear liquid medication ready for injection. The syringe includes a plunger and a needle end, depicted in a simple black and white line drawing.*
FDA Label Image

Enoxaparin Ifu Figure E (Enoxaparin 14)

Enoxaparin Ifu Figure E (Enoxaparin 14)
An instructional diagram labeled 'Figure E' showing a simplified outline of a human torso with shaded rectangular areas on the left and right sides, likely indicating recommended injection sites for a subcutaneous route.*
FDA Label Image

Enoxaparin Ifu Figure F (Enoxaparin 15)

Enoxaparin Ifu Figure F (Enoxaparin 15)
Illustration showing a hand depositing a piece of paper or waste material into a waste receptacle or trash bin. The image is a simple line drawing used likely for instructional or disposal guidance purposes.*
FDA Label Image

Enoxaparin Ifu Figure G (Enoxaparin 16)

Enoxaparin Ifu Figure G (Enoxaparin 16)
An instructional diagram labeled Figure G showing two hands preparing a syringe for injection. One hand is holding and removing the cap from the needle, while the other hand holds the syringe body, indicating the motion direction with arrows.*
FDA Label Image

Enoxaparin Ifu Figure H (Enoxaparin 17)

Enoxaparin Ifu Figure H (Enoxaparin 17)
An instructional illustration showing a hand holding an injection syringe. The image emphasizes setting the dose by aligning the plunger with a marked level on the syringe barrel, with a downward arrow indicating the plunger movement to set the dose.*
FDA Label Image

Enoxaparin Ifu Figure I (Enoxaparin 18)

Enoxaparin Ifu Figure I (Enoxaparin 18)
An illustration showing a hand giving a subcutaneous injection in the arm. The image may demonstrate the proper technique or location for administering an injection, relevant to Enoxaparin Sodium injection.*
FDA Label Image

Enoxaparin Ifu Figure J (Enoxaparin 19)

Enoxaparin Ifu Figure J (Enoxaparin 19)
Instructional illustration showing the proper subcutaneous injection technique for Enoxaparin Sodium injection. It depicts an injection being administered at a 90-degree angle to the skin, with one hand stabilizing the skin and the other hand holding the syringe.*
FDA Label Image

Enoxaparin Ifu Figure K (Enoxaparin 20)

Enoxaparin Ifu Figure K (Enoxaparin 20)
An instructional diagram labeled Figure K showing a hand administering a subcutaneous injection with a syringe into the abdominal area of a person's body, illustrating the injection technique for Enoxaparin Sodium injection.*
FDA Label Image

Enoxaparin Ifu Figure L (Enoxaparin 21)

Enoxaparin Ifu Figure L (Enoxaparin 21)
An instructional illustration showing the proper technique for administering a subcutaneous injection with a syringe into the abdominal area. The image depicts a hand holding a syringe perpendicular to the skin near the abdomen.*
FDA Label Image

Enoxaparin Ifu Figure M (Enoxaparin 22)

Enoxaparin Ifu Figure M (Enoxaparin 22)
An instructional diagram showing a hand holding an Enoxaparin Sodium injection syringe with a protective sleeve. The illustration indicates pressing or clicking action on the syringe with an arrow and the word "CLICK." This likely relates to usage or activation of the injection device.*
FDA Label Image

Enoxaparin Ifu Figure N (Enoxaparin 23)

Enoxaparin Ifu Figure N (Enoxaparin 23)
Instructional diagram showing a hand disposing of an Enoxaparin syringe into a sharps disposal container. The syringe and needle cap are labeled, illustrating safe syringe disposal procedures for Enoxaparin Sodium injection.*
FDA Label Image

30mg-carton (Enoxaparin 24)

30mg-carton (Enoxaparin 24)
The packaging label for Enoxaparin Sodium Injection, USP 30 mg/0.3 mL by Sandoz Inc features a white box with blue text. It states the product is a single-dose syringe with an automatic safety device for subcutaneous injection. The label includes dosing instructions, manufacturer details, storage conditions, and barcodes, designed to contain ten 0.3 mL syringes.*
FDA Label Image

40mg-carton (Enoxaparin 25)

40mg-carton (Enoxaparin 25)
Packaging label for Enoxaparin Sodium Injection, USP 40 mg/0.4 mL, a single-dose subcutaneous injection supplied in syringes with an automatic safety device. The label shows the product name, strength, dosage form, route, and manufacturer Sandoz Inc. It also includes directions for use, storage information, and package contents of ten 0.4 mL syringes.*
FDA Label Image

60mg-carton (Enoxaparin 26)

60mg-carton (Enoxaparin 26)
Packaging label for Enoxaparin Sodium Injection, USP, 60 mg/0.6 mL strength in single-dose syringes with automatic safety device, intended for subcutaneous injection. The label indicates a package containing ten 0.6 mL syringes. Manufactured by Sandoz Inc, the label includes dosing instructions and safety information, dimensions for folding, and barcodes.*
FDA Label Image

80mg-carton (Enoxaparin 27)

80mg-carton (Enoxaparin 27)
Packaging label for Enoxaparin Sodium Injection, USP 80 mg/0.8 mL by Sandoz Inc. The label indicates single-dose syringes with an automatic safety device for subcutaneous injection, with a quantity of ten 0.8 mL syringes per package. Directions for use and storage instructions are also included on the label.*
FDA Label Image

100mg-carton (Enoxaparin 28)

100mg-carton (Enoxaparin 28)
Packaging label for Enoxaparin Sodium Injection, USP 100 mg/mL, 1 mL single-dose syringes with an automatic safety device, manufactured by Sandoz Inc. The label includes dosage form, route of administration (subcutaneous injection), storage instructions, manufacturer details, and dose usage directions.*
FDA Label Image

120mg-carton (Enoxaparin 29)

120mg-carton (Enoxaparin 29)
Box packaging label for Enoxaparin Sodium Injection, USP 120 mg/0.8 mL by Sandoz Inc. The label indicates single-dose syringes with an automatic safety device for subcutaneous injection. The box shows usage directions and cautions, with measurements for box dimensions also visible.*
FDA Label Image

150mg-carton (Enoxaparin 30)

150mg-carton (Enoxaparin 30)
Packaging label for Enoxaparin Sodium Injection, USP 150 mg/mL by Sandoz Inc. The label is for single-dose syringes with automatic safety device for subcutaneous injection. It includes dosage details, storage instructions, warnings, and directions for use. The package size is ten 1 mL syringes. The design is predominantly white with blue text and branding.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.